IMPase in Treatment-resistant Depression

NCT05117710 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Depressive Disorder, Treatment-Resistant

Interventions

DRUG: Ebselen
DRUG: Placebo

Sponsor

University of Oxford

Collaborators

[object Object]
[object Object]